ARYA Sciences Acquisition Corp IV (ARYD) Financial Statements (2024 and earlier)

Company Profile

Business Address 51 ASTOR PLACE, 10TH FLOOR
NEW YORK, NY 10003
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 677 - Blank Checks (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments141860912350
Cash and cash equivalents141860912350
Prepaid expense1582645455151246
Total current assets:171282114146174296
Noncurrent Assets
Asset, held-in-trust39,63138,70638,106151,629150,448149,703
Total noncurrent assets:39,63138,70638,106151,629150,448149,703
TOTAL ASSETS:39,80238,98838,220151,775150,622149,999
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,3986,6046,7876,0615,9675,939
Accounts payable898069666767
Accrued liabilities7,3086,5246,7185,9955,9005,872
Debt1,7051,260720120  
Other liabilities180150    
Due to related parties120906030
Total current liabilities:9,2838,0147,6276,2716,0275,969
Noncurrent Liabilities
Other undisclosed noncurrent liabilities2,6162,6162,6162,6162,6165,233
Total noncurrent liabilities:2,6162,6162,6162,6162,6165,233
Total liabilities:11,89910,63010,2438,8878,64311,201
Temporary equity, carrying amount39,53138,60638,006151,529150,348149,603
Equity
Equity, attributable to parent, including:(11,628)(10,248)(10,029)(8,640)(8,369)(10,805)
Accumulated deficit(11,628)(10,248)(10,029)(8,641)(8,370)(10,806)
Other undisclosed equity, attributable to parent000000
Total equity:(11,628)(10,248)(10,029)(8,640)(8,369)(10,805)
TOTAL LIABILITIES AND EQUITY:39,80238,98838,220151,775150,622149,999

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues
(Realized Investment gains)
505     
Gross profit:505     
Operating expenses(960)(79)(969)(271)(180)(305)
Other undisclosed operating loss(505)     
Operating loss:(960)(79)(969)(271)(180)(305)
Nonoperating income
(Investment Income, Nonoperating)
  4601,1291,181745109
Income (loss) from continuing operations:(960)382160910565(196)
Income (loss) before gain (loss) on sale of properties:565(196)
Net income (loss):(960)382160910565(196)
Other undisclosed net income (loss) attributable to parent505  (2,616)2,616 
Net income (loss) available to common stockholders, diluted:(455)382160(1,706)3,181(196)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income (loss):(960)382160910565(196)
Comprehensive income (loss), net of tax, attributable to parent:(960)382160910565(196)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: